Evidence Hub

Formulation and In-vitro Characterisation of nasal In-Situ Gel for treatment of Anti-migraine Drug

Ashwin Pahurkar, Dr. Nishan N. Bobade, Dr. Shrikant D. Pande, Dr. Sandeep C. Atram, Dr. Vikrant P. Wankhade

Asian Journal of Pharmaceutical Research and Development, 2026

Abstract

The present study aimed to develop and evaluate a temperature-dependent nasal in situ gel of Rizatriptan benzoate for enhanced nasal residence time and improved bioavailability in migraine therapy. Rizatriptan benzoate undergoes extensive first-pass metabolism, resulting in low oral bioavailability. To overcome this limitation, a thermosensitive nasal in situ gel system was prepared using polymers such as Chitosan HCl, Sodium β-Glycerophosphate, Sodium alginate, and Gellan gum. The formulations were evaluated for physicochemical parameters including pH, gelation temperature, viscosity, mucoadhesive strength, drug content, and in vitro drug release. The optimized formulation FF5 showed satisfactory gelation at nasal temperature, good mucoadhesion, and sustained drug release over 8 hours. Drug release kinetics revealed diffusion-controlled release following the Higuchi model. Stability studies indicated that the optimized formulation remained stable under different storage conditions. The developed temperature-dependent nasal in situ gel demonstrated potential as an effective and patient-friendly approach for sustained nasal delivery of Rizatriptan benzoate.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free